This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cardiome Pharma Corp (CRME)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 12.71M 10.98M 41.27M 48.64M
Receivables 9.50M 6.67M 978.00K 1.25M
Inventories 5.34M 6.60M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 32.01M 28.33M 43.02M 50.52M
Property, Plant & Equipment, Gross 1.57M 1.23M 782.00K 8.40M
Accumulated Depreciation & Depletion 758.00K 615.00K 511.00K 6.44M
Property, Plant & Equipment, Net 811.00K 618.00K 271.00K 1.97M
Intangibles 16.16M 18.07M 1.51M 1.55M
Other Non-Current Assets 821.00K 0.00 0.00 0.00
Total Non-Current Assets 18.11M 19.00M 1.78M 3.52M
Liabilities & Shareholder Equity
Total Assets 50.12M 47.33M 44.79M 54.04M
Accounts Payable 5.47M 6.45M 1.04M 351.00K
Short Term Debt 1.71M 0.00 32.50M 0.00
Other Current Liabilities 0.00 0.00 0.00 116.00K
Total Current Liabilities 18.15M 17.69M 36.93M 3.30M
Long Term Debt 10.29M 0.00 0.00 25.00M
Deferred Income Taxes 4.54M 7.00M 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 445.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 14.83M 7.00M 0.00 25.44M
Total Liabilities 32.98M 24.69M 36.93M 28.75M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 17.14M 22.64M 7.86M 25.29M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 318.99M 305.43M 295.19M 294.30M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -318.97M -300.75M -305.52M -287.20M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 17.12M 17.96M 18.18M 18.18M
Total Capitalization 27.42M 22.64M 7.86M 50.29M
Total Equity 17.14M 22.64M 7.86M 25.29M
Total Liabilities & Stock Equity 50.12M 47.33M 44.79M 54.04M
Total Common Shares Outstanding 16.59M 14.96M 12.47M 12.23M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 16.23M 12.77M 12.25M 12.23M
Diluted Weighted Shares Outstanding 16.23M 12.93M 12.25M 12.23M
Number of Employees 85 75 13 92
Number of Part-Time Employees 0 0 0 0

CRME Cardiome Pharma Corp

Chart of CRME

Analysts Ratings for CRME

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

CRME Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs